Search Results - "Padula, W"

Comparing tyrosine kinase inhibitor treatment strategies for newly diagnosed chronic myeloid leukemia in chronic phase when imatinib loses patent exclusivity in the u.s.: a cost-effectiveness analysis by Padula, W, Larson, R, Conti, R, Dusetzina, S

Get full text

Are evidence-based practices associated with effective prevention of hospital-acquired pressure ulcers in u.s. Hospitals? by Padula, W, Gibbons, R.D, Valuck, R.J, Makic, M.B, Meltzer, D

Get full text

Determining the cost of obesity and its common comorbidities from a commercial claims database by Padula, W. V., Allen, R. R., Nair, K. V.

“…Summary What is already known about this subject Obesity is highly prevalent and costly in the US. Obesity often leads to other comorbid conditions, including…”
Get full text

P16 Generalized Prevalence-Adjusted Willingness-to-Pay to Control for Health Equity in Cost-Effectiveness Analysis by Pontinha, V., Padula, W.

Get full text

HSD56 Utilization of Vascular Assessment Before Lower Extremity Amputation Among Patients With Diabetic Foot Ulcerations in the US by Zheng, H., Padula, W., Tan, T.W.

Get full text

EE35 Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Vs. Pembrolizumab Plus Chemotherapy for the First-Line Treatment of Non-Squamous, Advanced Non-Small Cell Lung Cancer in the USA by Chen, J, Velcheti, V, Padula, W

Get full text

P18 Assessing the Value of Revascularization Strategies for Chronic Limb Threatening Ischemia in Patients with Diabetic Foot Ulcers: A Propensity Score-Weighted Evaluation by Zheng, H., Tan, T.W., Armstrong, D.G., Padula, W.

Get full text

HPR4 $20.9 Billion Annually Wasted on “Defects in Value” for Total Knee and Hip Replacements in the United States by Cohen, B., Chen, J., Zheng, H., Pronovost, P.J., Padula, W.

Get full text

HSD90 Value as the Next Innovation in Rectal Cancer Surgery: A Review by Dietz, D., Padula, W., Zheng, H., Monson, J., Pronovost, P.J.

Get full text

EE419 Cost-Effectiveness Analysis of Non-Invasive Screening in Patients with Diabetic Foot Ulcers by Gu, B, Padula, W, Armstrong, DG

Get full text

EE245 Cost-Effectiveness of Therapeutic Hypothermia for Neonates with Mild Hypoxic-Ischemic Encephalopathy by Davis, I, Gong, CL, Padula, W, Yieh, L

Get full text

EE395 Cost-Effectiveness of Respiratory Syncytial Virus Prophylaxis in Preterm Infants 29-35 Weeks' Gestation by Yu, T, Padula, W, Yieh, L, Gong, CL

Get full text

EE288 A Cost-Effectiveness Analysis of Biologic Compared with Chemical Disease Modifying Drugs in Treating Multiple Sclerosis in US by Jin, S, Amezcua, L, Moghavem, N, Padula, W

Get full text

PIH10 A Cost-Effectiveness Analysis of Repositioning Intervals for Pressure Injury Prevention: An Economic Evaluation of the "TEAM-up” Clinical Trial by Crawford, S., Padula, W., Kennerly, S., Yap, T.L.

Get full text

EE209 Value Defects in Spine Surgery: How to Reduce Wasteful Care and Improve Value by Padula, W., Zheng, H., Chen, J., Smith, G.A., Gordon, Z., Pronovost, P.J.

Get full text

PIH16 ESTIMATING THE VALUE OF NURSING TIME TO REDUCE COSTS AND INCREASE QUALITY OF PRESSURE INJURY PREVENTION IN NURSING HOMES: A COST-EFFECTIVENESS ANALYSIS OF THE TEAM-UP CLINICAL TRIAL by Padula, W., Crawford, S., Kennerly, S., Yap, T.L.

Get full text

EE136 Cost-Effectiveness Analysis of Tisagenlecleucel Using Long-Term Survival Outcomes in Treating Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma from US Societal Perspective by Choe, J, Abdel-Azim, H, Abou-el-Enein, M, Padula, W

Get full text

EE342 Compression Therapy with Early Endovenous Ablation in Venous Leg Ulceration in the U.S.: A Cost-Effectiveness Analysis by Zheng, H, Magee, GA, Tan, TW, Armstrong, DG, Padula, W

Get full text

Visual evoked potentials (VEP) evaluating treatment for post-trauma vision syndrome (PTVS) in patients with traumatic brain injuries (TBI) by Padula, W V, Argyris, S, Ray, J

“…Post-trauma vision syndrome (PTVS), which is characterized by binocular function problems, may be caused by dysfunction of the ambient visual process which is…”
Get more information

EE404 A Cost-Effectiveness Analysis of a Triple-Agent Topical Fixed-Dose Combination of 1.2% Clindamycin Phosphate, 0.15% Adapalene, and 3.1% Benzoyl Peroxide Gel for the Treatment of Moderate-to-Severe Acne Vulgaris in the United States by Dey, D, Harper, J, Paul, Choudhury S, Dutta, S, Thomas, A, Bhattacharyya, S, Padula, W, Lin, T, Olujohungbe, O, Jospeh, G, Dashputre, A

Get full text